Literature DB >> 2518609

Usefulness of serology for the evaluation of Trypanosoma cruzi transmission in endemic areas of Chagas' disease.

R Chuit, E Subias, A C Pérez, I Paulone, C Wisnivesky-Colli, E L Segura.   

Abstract

Thirteen communities from 7 Argentinian provinces were selected for the evaluation of serology as an indicator of transmission of Chagas disease. Of the communities appraised, 6 did not have a history of previous treatment with insecticides and 7 had received sporadic or continuous insecticide treatment. The inhabitants of 20% of the houses of each locality were studied by serology. The samples were obtained by finger pricking and 50 microliters of blood were mixed with 15 microliter of 50% glycerine solution in tissue culture media to be assayed by Indirect Hemagglutination and Indirect Immunofluorescence tests. In untreated areas, the prevalence of infection in infants 0-4 years old was 17.5%, reaching to over 22% for the 5-9 year old group, and to 33.3% in 10-14 year old individuals. The prevalence in treated and surveyed areas was 2.6% in 0-4 year old children, 5.4% in 5-9 year old and 6.2% in 10-14 year old youngsters. The differences between both areas were statistically significant (p less than 0.005). This study favors serology as a valid indicator for the evaluation of transmission of Chagas disease in rural areas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2518609     DOI: 10.1590/s0037-86821989000300002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

1.  Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina.

Authors:  Ricardo E Gürtler; Uriel Kitron; M Carla Cecere; Elsa L Segura; Joel E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

2.  Surveillance of Trypanosoma cruzi transmission by serological screening of schoolchildren.

Authors:  A L de Andrade; F Zicker; A O Luquetti; R M Oliveira; S A Silva; J M Souza; C M Martelli
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.